These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 28272130)

  • 21. The dual diagnosis of attention-deficit/hyperactivity disorder and substance abuse: case reports and literature review.
    Schubiner H; Tzelepis A; Isaacson JH; Warbasse LH; Zacharek M; Musial J
    J Clin Psychiatry; 1995 Apr; 56(4):146-50. PubMed ID: 7713853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [ADHD in adult patients with substance use disorders].
    Luderer M; Kiefer F; Reif A; Moggi F
    Nervenarzt; 2019 Sep; 90(9):926-931. PubMed ID: 31407043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attention deficit hyperactivity disorder and dual disorders. Educational needs for an underdiagnosed condition.
    Martinez-Raga J; Szerman N; Knecht C; de Alvaro R
    Int J Adolesc Med Health; 2013; 25(3):231-43. PubMed ID: 23846135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of adults with attention deficit hyperactivity disorder plus substance use disorder: the role of psychiatric comorbidity.
    Wilens TE; Kwon A; Tanguay S; Chase R; Moore H; Faraone SV; Biederman J
    Am J Addict; 2005; 14(4):319-27. PubMed ID: 16188712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacotherapy of adolescent substance use disorders: a review of the literature.
    Waxmonsky JG; Wilens TE
    J Child Adolesc Psychopharmacol; 2005 Oct; 15(5):810-25. PubMed ID: 16262597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Need for care and life satisfaction in adult substance use disorder patients with and without attention deficit hyperactivity disorder (ADHD) or autism spectrum disorder (ASD).
    Kronenberg LM; Goossens PJ; van Etten DM; van Achterberg T; van den Brink W
    Perspect Psychiatr Care; 2015 Jan; 51(1):4-15. PubMed ID: 24410895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcomes of pharmacologically treated versus non-treated adults with ADHD and substance use disorder: a naturalistic study.
    Bihlar Muld B; Jokinen J; Bölte S; Hirvikoski T
    J Subst Abuse Treat; 2015 Apr; 51():82-90. PubMed ID: 25491733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment strategies for co-occurring ADHD and substance use disorders.
    Mariani JJ; Levin FR
    Am J Addict; 2007; 16 Suppl 1(Suppl 1):45-54; quiz 55-6. PubMed ID: 17453606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [ADHD in Adults and Comorbid Substance Use Disorder: Prevalence, Clinical Diagnostics and Integrated Therapy].
    Dirks H; Scherbaum N; Kis B; Mette C
    Fortschr Neurol Psychiatr; 2017 Jun; 85(6):336-344. PubMed ID: 28645126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Substance use disorders and ADHD: an overview of recent Dutch research].
    van Emmerik-van Oortmerssen K; Crunelle CL; Carpentier PJ
    Tijdschr Psychiatr; 2013; 55(11):861-6. PubMed ID: 24242145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.
    Carpentier PJ; de Jong CA; Dijkstra BA; Verbrugge CA; Krabbe PF
    Addiction; 2005 Dec; 100(12):1868-74. PubMed ID: 16367988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacotherapy of adult Attention Deficit/Hyperactivity Disorder (ADHD): a systematic review].
    Mészáros A; Czobor P; Bálint S; Simon V; Bitter I
    Psychiatr Hung; 2007; 22(4):259-70. PubMed ID: 18167421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues.
    Wilens TE
    Psychiatr Clin North Am; 2004 Jun; 27(2):283-301. PubMed ID: 15063998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents.
    Wilens TE; Adamson J; Monuteaux MC; Faraone SV; Schillinger M; Westerberg D; Biederman J
    Arch Pediatr Adolesc Med; 2008 Oct; 162(10):916-21. PubMed ID: 18838643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attention deficit hyperactivity disorder and substance abuse: An investigation in young Austrian males.
    Riegler A; Völkl-Kernstock S; Lesch O; Walter H; Skala K
    J Affect Disord; 2017 Aug; 217():60-65. PubMed ID: 28391109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical exploration of co-occurring Attention-Deficit/Hyperactivity Disorder, mood disorder and Substance Use Disorder.
    Regnart J; Truter I; Meyer A
    Expert Rev Pharmacoecon Outcomes Res; 2017 Jun; 17(3):275-282. PubMed ID: 28686107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Searching for a neurobiological basis for self-medication theory in ADHD comorbid with substance use disorders: an in vivo study of dopamine transporters using (99m)Tc-TRODAT-1 SPECT.
    Silva N; Szobot CM; Shih MC; Hoexter MQ; Anselmi CE; Pechansky F; Bressan RA; Rohde LA
    Clin Nucl Med; 2014 Feb; 39(2):e129-34. PubMed ID: 23856832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylphenidate DAT binding in adolescents with Attention-Deficit/ Hyperactivity Disorder comorbid with Substance Use Disorder--a single photon emission computed tomography with [Tc(99m)]TRODAT-1 study.
    Szobot CM; Shih MC; Schaefer T; Júnior N; Hoexter MQ; Fu YK; Pechansky F; Bressan RA; Rohde LA
    Neuroimage; 2008 Apr; 40(3):1195-201. PubMed ID: 18282769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Impact of Pharmacotherapy on Substance Use in Adolescents With Attention-Deficit/Hyperactivity Disorder: Variations Across Subtypes.
    Upadhyay N; Chen H; Mgbere O; Bhatara VS; Aparasu RR
    Subst Use Misuse; 2017 Aug; 52(10):1266-1274. PubMed ID: 28323525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Adult ADHD: clinical aspects and therapeutic implications].
    Ceraudo G; Vannucchi G; Perugi G; Dell'osso L
    Riv Psichiatr; 2012; 47(6):451-64. PubMed ID: 23160106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.